SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Aldeyra Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 29, 2023 - (NASDAQ: ALDX)PRNewsWire • 09/27/23
ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud LawsuitPRNewsWire • 09/26/23
FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in Aldeyra Therapeutics, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 09/26/23
DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Aldeyra Therapeutics, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 09/24/23
FINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in Aldeyra Therapeutics, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 09/22/23
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Aldeyra Therapeutics, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 09/21/23
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Aldeyra Investors of a Lead Plaintiff Deadline of September 29, 2023PRNewsWire • 09/18/23
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important September 29 Deadline in Securities Class Action - ALDXPRNewsWire • 09/16/23
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders of a Class Action against Aldeyra Therapeutics, Inc. and Certain Officers - ALDXPRNewsWire • 09/13/23
SHAREHOLDER ALERT: Potential Recovery for Aldeyra Therapeutics, Inc. (ALDX) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action LawsuitAccesswire • 09/11/23
SHAREHOLDER ALERT: Potential Recovery for Aldeyra Therapeutics, Inc. (ALDX) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action LawsuitAccesswire • 09/11/23
ROSEN, A TOP RANKED LAW FIRM, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALDXPRNewsWire • 09/09/23
ROSEN, A LEADING LAW FIRM, Encourages Aldeyra Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ALDXPRNewsWire • 09/02/23
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ALDXBusiness Wire • 08/31/23
SHAREHOLDER ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 29, 2023 in the Class Action Filed on Behalf of Aldeyra Therapeutics, Inc.(ALDX) ShareholdersPRNewsWire • 08/28/23
ROSEN, A LEADING LAW FIRM, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALDXPRNewsWire • 08/25/23
Investors who lost over $100,000 with Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between March 2022 and June 2023 should contact the Shareholders Foundation in connection with LawsuitPRNewsWire • 08/22/23
Calling All Aldeyra Therapeutics, Inc. (ALDX) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action LawsuitBusiness Wire • 08/21/23
ALDX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Aldeyra Therapeutics, Inc.Accesswire • 08/21/23
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Aldeyra Therapeutics, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 08/19/23
ROSEN, A LEADING LAW FIRM, Encourages Aldeyra Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - ALDXPRNewsWire • 08/19/23
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders of a Class Action Against Aldeyra Therapeutics, Inc. and Certain Officers - ALDXPRNewsWire • 08/18/23
ALDX LAWSUIT ALERT: Levi & Korsinsky Notifies Aldeyra Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlinePRNewsWire • 08/17/23
ALDX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 29, 2023 in the Class Action Filed on Behalf of Aldeyra Therapeutics, Inc. ShareholdersPRNewsWire • 08/15/23
